Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
50,445,144
-
Share change
-
+2,175,658
-
Total reported value
-
$5,226,929,070
-
Put/Call ratio
-
37%
-
Price per share
-
$103.67
-
Number of holders
-
218
-
Value change
-
+$253,491,603
-
Number of buys
-
119
-
Number of sells
-
98
Institutional Holders of KITE PHARMA INC - COM (KITE) as of Q2 2017
As of 30 Jun 2017,
KITE PHARMA INC - COM (KITE) was held by
218 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,445,144 shares.
The largest 10 holders included
Capital Research Global Investors, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Inc., Capital World Investors, Wildcat Capital Management, LLC, JPMORGAN CHASE & CO, Partner Fund Management, L.P., STATE STREET CORP, and Capital International Investors.
This page lists
218
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.